---
title: "Replimune Group GAAP EPS of -$3.38 misses by $0.02"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291143834.md"
description: "Replimune Group reported a GAAP EPS of -$3.38, missing estimates by $0.02. As of March 31, 2026, cash and short-term investments stood at $268.9 million, down from $483.8 million in the prior fiscal year due to operating cash burn for clinical development. The company expects existing funds to support operations through Q1 2027, covering commercialization scale-up for RP1 and general corporate needs."
datetime: "2026-06-29T12:15:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291143834.md)
  - [en](https://longbridge.com/en/news/291143834.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291143834.md)
---

# Replimune Group GAAP EPS of -$3.38 misses by $0.02


### Related Stocks

- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)

## Related News & Research

- [Replimune announces annual shareholder meeting](https://longbridge.com/en/news/294186963.md)
- [Replimune Lead Drug Trial Data Deemed 'Not Interpretable' by FDA Staff](https://longbridge.com/en/news/294101082.md)
- [Katahdin Bankshares GAAP EPS of $0.76](https://longbridge.com/en/news/293976481.md)
- [California Water Service GAAP EPS of $0.93 misses by $0.14, revenue of $308.6M misses by $28.8M](https://longbridge.com/en/news/294369983.md)
- [Canfor GAAP EPS of -$0.16, revenue of $1.53B beats by $520M](https://longbridge.com/en/news/294297554.md)